Navigation Links
Nventa announces publication of HspE7 data
Date:9/24/2007

- HspE7 Demonstrates Ability to Elicit Long-Lasting Tumor Protection In

Vivo; Lead Candidate May Have Utility in HPV-infected Patients With

Invasive Cancer and/or HIV -

SAN DIEGO, CA, Sept. 24 /PRNewswire-FirstCall/ - Nventa Biopharmaceuticals Corporation (TSX:NVN) today announced the publication of in vivo results of its lead therapeutic vaccine candidate for the treatment of human papillomavirus (HPV)-related diseases, HspE7, in Clinical and Vaccine Immunology, August 2007. The results reported originate from a study undertaken to characterize the cellular anti-E7 immune response induced by HspE7 and to determine the optimum dosing regimen for inducing effective antitumor immunity.

These published study results demonstrated that a single injection of HspE7 is capable of eliciting long-lasting memory CD8+ T cells and conferring protection against tumor challenges in mice lacking CD4+ functions. CD8+ T cells are a type of white blood cell capable of inducing the death of infected somatic or tumor cells by killing cells infected with viruses (or other pathogens) or otherwise damaged or dysfunctional. These data further demonstrated that two HspE7 immunizations protected a higher proportion of mice for a longer duration.

"These results further strengthen our belief that HspE7 is a promising immunotherapeutic agent for treating HPV-related diseases," said Peter Emtage, Ph.D., Vice President, Research and Development at Nventa. "The ability of HspE7 to induce memory CD8+ T cells in the absence of CD4+ help is significant and suggests that our HspE7 fusion protein may have utility in individuals with compromised CD4+ functions, such as those with invasive cancer and/or human immunodeficiency virus infection."

HPV has been detected in most anogenital cancers, and HPV type 16 (HPV16) is closely associated with severe cervical dysplasia and with cervical, anal and approximately 25 percent of head and neck cancers
'/>"/>

SOURCE Nventa Biopharmaceuticals Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 Tris Pharma, a ... technologies, today announced that it has been selected as ... Industry Association,s 2014 Awards for Excellence competition ... an independent panel of judges from SCORE (Counselors to ... winners will be honored at a gala event to ...
(Date:8/27/2014)... BIOEQUA, an innovative line of skin care ... handheld spray, has made its EQUA ESSENTIAL line available ... brand began with an unexpected discovery in an emergency ... that the application of nanospray technology allowed for liquid ... to skin's basal layer. This resulted in immediate absorption ...
(Date:8/27/2014)... White City, OR (PRWEB) August 27, 2014 ... Supply Report, “Consolidation continues to reshape the look and ... in nutrition. Consumer demand for higher-quality ingredients will push ... the North American market have experienced strong market growth ... and ethical attributes in their food and cosmetics to ...
(Date:8/27/2014)... WriteResult, LLC – a premier provider of ... superiority when it comes to meeting the needs of ... of their most recent study closeout on-time and with ... digital writing platform to collect Patient Reported Outcomes electronically ... drew data from a number of assessments including the ...
Breaking Biology Technology:Tris Pharma Selected as an award winner in the New Jersey Business & Industry Association's 2014 Awards for Excellence 2BIOEQUA'S EQUA ESSENTIAL Product Line Redefines Skin Care & Now Available in America 2Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 2Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 3A Perfect Record: WriteResult Maintains a 100% On-Time ePRO Record with Latest Irritable Bowel (IBS) Study Data Lock 2
... chips are in demand. RUB physicists have discovered a ... Padma Kant Shukla and Dr. Bengt Eliasson found a ... potential makes it possible to combine positively charged particles ... way, current can be conducted much more quickly and ...
... The L,ORÉAL-UNESCO For Women in Science program is welcoming the ... and debates. , On Wednesday, March 28, from ... their research at the Pasteur Institute in Paris. Following these ... International Fellows can be met individually , ...
... populations, once thriving in zoos, have been showing ... San Diego Zoo Global researchers have a possible ... in managed-care facilities is declining: phytoestrogens in their ... the females. , "Understanding why the captive white ...
Cached Biology Technology:When ions get closer 2The 14th Annual L'Oréal-Unesco Awards or Women on Science: From March 26 to March 29, Paris Welcomes and Honours Tomorrow's Scientific Talents 2The 14th Annual L'Oréal-Unesco Awards or Women on Science: From March 26 to March 29, Paris Welcomes and Honours Tomorrow's Scientific Talents 3The 14th Annual L'Oréal-Unesco Awards or Women on Science: From March 26 to March 29, Paris Welcomes and Honours Tomorrow's Scientific Talents 4
(Date:8/27/2014)... (June, 2014) Outstanding basic research, a growing ... dedication to patient care have earned the Herbert ... Medical Center (CUMC) and NewYork-Presbyterian Hospital an $18 ... National Cancer Institute (NCI). The grant renews the ... Comprehensive Cancer Centers in New York City and ...
(Date:8/27/2014)... studies have shown that excessive iron is ... disease. Previous studies from Chunyan Guo and ... have shown that baicalin prevented iron accumulation ... transporter 1 expression, and increased ferroportin 1 ... Parkinson,s disease rats. However, the relationship between ...
(Date:8/27/2014)... Happy Camp Complex of fires had consumed 24,939 acres ... consumed 35,530 as of eight hours ago. , ... Ranger District of the Klamath National Forest when a ... All but three of those fires are now 100 ... fires and their size at containment: Delta, 150 acres; ...
Breaking Biology News(10 mins):Herbert Irving Comprehensive Cancer Center awarded $18 million grant 2Herbert Irving Comprehensive Cancer Center awarded $18 million grant 3Herbert Irving Comprehensive Cancer Center awarded $18 million grant 4Happy Camp and July Fire Complexes in California 2
... Splitting hydrogen and oxygen from water using conventional electrolysis ... plants produce oxygen from water efficiently using a catalytic ... part of photosynthesis and so effective that it is ... mimicked by artificial systems, this photocatalytic process could provide ...
... Plant leaves are protected from drying out by an airtight ... called stomata. Every year 40% of atmospheric CO 2 ... pass through these pores. This means that stomata are not ... It,s no surprise then that these pores appear ...
... be able to boost the effects of two standard ... stage trial data published in Clinical Cancer Research. ... paclitaxel chemotherapy in combination with intravenous oncolytic reovirus in ... Karapanagiotou from the ICR and The Royal Marsden was ...
Cached Biology News:Scientists study the catalytic reactions used by plants to split oxygen from water 2Scientists study the catalytic reactions used by plants to split oxygen from water 3Stomata development in plants unraveled -- a valuable discovery for environmental research 2Harmless human virus may be able to boost the effects of chemotherapy 2
Request Info...
... The Cetac Ultrasonic Nebulizers are available in two ... difference between these two models is that the ... to create a drier aerosol for improved detection ... detection limits for a range of elements by ...
... potent inhibition of RNase A-type ribonucleases Product ... of nonhuman origin that binds noncovalently and ... A, B, and C). It does not ... U2, or CL3. QIAGEN RNase Inhibitor inhibits ...
... Radiochemical Purity is >95%NEN Radiolabeled Ligands\n\nReceptor-related ... continual availability of new radiolabeled ligands selected ... offers a wide range of products and ... including over 400 state-of-the-art radioligands. If you ...
Biology Products: